Percutaneous patent foramen ovale closure using the Occlutech Figulla device: More than 1,300 patient ‐years of follow up

ConclusionThe Occlutech device appears to be safe at long ‐term FU with a very low annual cerebrovascular event rate and a low moderate to large shunt rate at 1‐year FU.

Source: Catheterization and Cardiovascular Interventions - November 20, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Roel J. R. Snijder, Laura E. Renes, Maarten Jan Suttorp, Jurrien M. ten Berg, Martijn C. Post Tags: VALVULAR AND STRUCTURAL HEART DISEASES Source Type: research